Sandy Vrignaud

881 total citations
19 papers, 515 citations indexed

About

Sandy Vrignaud is a scholar working on Biomaterials, Pharmaceutical Science and Surgery. According to data from OpenAlex, Sandy Vrignaud has authored 19 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Biomaterials, 4 papers in Pharmaceutical Science and 3 papers in Surgery. Recurrent topics in Sandy Vrignaud's work include Nanoparticle-Based Drug Delivery (6 papers), Advanced Drug Delivery Systems (4 papers) and Safe Handling of Antineoplastic Drugs (3 papers). Sandy Vrignaud is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Advanced Drug Delivery Systems (4 papers) and Safe Handling of Antineoplastic Drugs (3 papers). Sandy Vrignaud collaborates with scholars based in France. Sandy Vrignaud's co-authors include Jean‐Pierre Benoît, Patrick Saulnier, Nicolas Anton, J. Hureaux, Séverine Wack, Frédéric Lagarce, Cédric Gaillard, Vincent Lisowski, Aurélie Malzert‐Fréon and Catherine Passirani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Langmuir.

In The Last Decade

Sandy Vrignaud

18 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandy Vrignaud France 9 206 162 139 89 80 19 515
Peter Scholes United Kingdom 9 221 1.1× 219 1.4× 108 0.8× 67 0.8× 105 1.3× 11 521
Anand Babu Dhanikula India 10 223 1.1× 191 1.2× 184 1.3× 67 0.8× 93 1.2× 14 603
Satish Shilpi India 14 261 1.3× 250 1.5× 225 1.6× 68 0.8× 113 1.4× 31 712
Taehoon Sim South Korea 14 240 1.2× 91 0.6× 150 1.1× 54 0.6× 181 2.3× 26 492
Keru Zhang China 8 184 0.9× 267 1.6× 162 1.2× 66 0.7× 117 1.5× 11 629
Mrunal Jadhav India 6 200 1.0× 129 0.8× 196 1.4× 95 1.1× 132 1.6× 8 584
Yating Fan China 12 121 0.6× 276 1.7× 152 1.1× 64 0.7× 88 1.1× 22 619
Gitu Pandey India 15 194 0.9× 130 0.8× 173 1.2× 52 0.6× 160 2.0× 19 566
Bao Le‐Vinh Austria 13 129 0.6× 222 1.4× 163 1.2× 82 0.9× 51 0.6× 18 467
Valamla Bhavana India 16 226 1.1× 216 1.3× 160 1.2× 42 0.5× 151 1.9× 27 712

Countries citing papers authored by Sandy Vrignaud

Since Specialization
Citations

This map shows the geographic impact of Sandy Vrignaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Vrignaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Vrignaud more than expected).

Fields of papers citing papers by Sandy Vrignaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandy Vrignaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Vrignaud. The network helps show where Sandy Vrignaud may publish in the future.

Co-authorship network of co-authors of Sandy Vrignaud

This figure shows the co-authorship network connecting the top 25 collaborators of Sandy Vrignaud. A scholar is included among the top collaborators of Sandy Vrignaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy Vrignaud. Sandy Vrignaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Leducq, Sophie, Sandy Vrignaud, G. Lorette, et al.. (2019). Topical rapamycin (sirolimus) for treatment of cutaneous microcystic lymphatic malformation of the gluteal area. European Journal of Dermatology. 29(1). 82–83. 2 indexed citations
2.
Vrignaud, Sandy, et al.. (2018). Successful treatment of a recurrent Aspergillus niger otomycosis with local application of voriconazole. Journal de Mycologie Médicale. 28(2). 396–398. 13 indexed citations
3.
Deshayes, Caroline, et al.. (2018). Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation. SHILAP Revista de lepidopterología. 3(4). 219–226. 3 indexed citations
4.
Vrignaud, Sandy. (2017). Resolution CM/Res(2016)2 and Centralised Intra Venous Additive Services (CIVAS): Challenges and Opportunities. SHILAP Revista de lepidopterología. 2(3). 3 indexed citations
5.
Vrignaud, Sandy, et al.. (2016). Using Preliminary Risk Analysis (PRA) to Ensure Safety in the Preparation Process for Parenteral Nutrition Bags in Hospital Pharmacy. SHILAP Revista de lepidopterología. 1(2). 2 indexed citations
6.
Vrignaud, Sandy, et al.. (2016). Mise en place d’une démarche d’habilitation du personnel en pharmacie hospitalière : application à la production de poches de nutrition parentérale. Annales Pharmaceutiques Françaises. 74(5). 389–403. 3 indexed citations
7.
Lagarce, Frédéric, et al.. (2016). Formulation and characterization of a 0.1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas. International Journal of Pharmaceutics. 509(1-2). 279–284. 13 indexed citations
8.
Vrignaud, Sandy, et al.. (2015). Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes. International Journal of Pharmaceutics. 492(1-2). 137–140. 7 indexed citations
9.
Vrignaud, Sandy, et al.. (2015). Design and stability study of a paediatric oral solution of methotrexate 2mg/ml. International Journal of Pharmaceutics. 487(1-2). 270–273. 10 indexed citations
11.
Vrignaud, Sandy, Nicolas Anton, Catherine Passirani, Jean‐Pierre Benoît, & Patrick Saulnier. (2013). Aqueous core nanocapsules: a new solution for encapsulating doxorubicin hydrochloride. Drug Development and Industrial Pharmacy. 39(11). 1706–1711. 24 indexed citations
12.
Vrignaud, Sandy, J. Hureaux, Séverine Wack, Jean‐Pierre Benoît, & Patrick Saulnier. (2012). Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. International Journal of Pharmaceutics. 436(1-2). 194–200. 60 indexed citations
13.
Vrignaud, Sandy, Jean‐Pierre Benoît, & Patrick Saulnier. (2011). Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 32(33). 8593–8604. 244 indexed citations
14.
Vrignaud, Sandy, et al.. (2011). Reverse micelle-loaded lipid nanocarriers: A novel drug delivery system for the sustained release of doxorubicin hydrochloride. European Journal of Pharmaceutics and Biopharmaceutics. 79(1). 197–204. 50 indexed citations
15.
Anton, Nicolas, et al.. (2009). Aqueous-Core Lipid Nanocapsules for Encapsulating Fragile Hydrophilic and/or Lipophilic Molecules. Langmuir. 25(19). 11413–11419. 42 indexed citations
16.
Malzert‐Fréon, Aurélie, Sandy Vrignaud, Patrick Saulnier, et al.. (2006). Formulation of sustained release nanoparticles loaded with a tripentone, a new anticancer agent. International Journal of Pharmaceutics. 320(1-2). 157–164. 32 indexed citations
17.
Vrignaud, Sandy, et al.. (2002). Syndrome bilatéral des loges de jambe après chirurgie colorectale en position à double équipe. Annales de Chirurgie. 127(7). 535–538. 4 indexed citations
18.
Bernard, Philippe, et al.. (2001). Mobilité anormale d’un cathéter de chambre implantable selon la posture chez une patiente obèse. Annales Françaises d Anesthésie et de Réanimation. 20(8). 720–722.
19.
Vrignaud, Sandy, et al.. (1991). Dermatite de contact par cathéter intraveineux périphérique à embase métallique. Annales Françaises d Anesthésie et de Réanimation. 10(5). 475–477. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026